Together these studies demonstrated that SliC provides a significant fitness benefit to N. gonorrhoeae in the murine model and offered the first evidence that a proteinaceous lysozyme c inhibitor is important during in vivo infection solely due to its ability to bind and inactivate lysozyme. Here, LYZ is linked to infection.